The present invention describes therapies for the effective treatment of colon and colorectal carcinomas. The present invention relates to a pharmaceutical kit comprising ibrutinib and fluorouracil, for the treatment of colon and colorectal carcinomas also in the case in which such carcinomas are drug resistant and therefore allows to overcome cancer drug resistance.